In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia
In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia
复制标题
DOI:
10.1097/00004647-200106000-00003
复制
发表时间:
2001-06-01
影响因子:
6.3
通讯作者:
Gruetter, R
中科院分区:
文献类型:
--
作者:
Choi, IY;Lee, SP;Gruetter, R
Glucose is the major substrate that sustains normal brain function. When the brain glucose concentration approaches zero, glucose transport across the blood-brain barrier becomes rate limiting for metabolism during. for example, increased metabolic activity and hypoglycemia. Steady-state brain glucose concentrations: in alpha -chloralose anesthetized rats were measured noninvasively as a function of plasma glucose. The relation between brain and plasma glucose was linear at 4.5 to 30 mmol/L plasma glucose, which is consistent with the reversible Michaelis-Menten model. When the model was fitted to the brain glucose measurements, the apparent Michaelis-Menten constant, K-t, was 3.3 +/- 1.0 mmol/L, and the ratio of the maximal transport rate relative to CMRglc, T-max/CMRglc, was 2.7 +/- 0.1, This K-t is comparable to the authors' previous human data. suggesting that glucose transport kinetics in humans and rats are similar. Cerebral blood flow (CBF) was simultaneously assessed and constant above 2 mmol/L plasma glucose at 73 +/- 6 mL 100 g(-1) min(-1). Extrapolation of the reversible Michaelis-Menten model to hypoglycemia correctly predicted the plasma glucose concentration (2.1 +/- 0.6 mmol/L) at which brain glucose concentrations approached zero. At this point, CBF increased sharply by 57% +/- 22%. suggesting that brain glucose concentration is the signal that triggers defense mechanisms aimed at improving glucose delivery to the brain during hypoglycemia.